CytomX Therapeutics
Price & Volume
Stats
See more52W Range | $0.40-$4.62 |
Market Cap | $601.4M |
Shares Short | 28M |
Financials
See moreRevenue (12 Mos) | $113.6M |
Revenue Growth (YoY) | -82.2% |
Gross Profit (12 Mos) | $113.6M |
Diluted EPS | $0.30 |
News
See moreYahoo Finance • 6 days ago
CytomX Therapeutics to Present at the Jefferies London Healthcare Conference
Yahoo Finance • 12 days ago
CytomX outlines Q1 2026 CX-2051 data update and 100-patient enrollment milestone as Phase Ib study nears
Yahoo Finance • 13 days ago
CytomX Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
Yahoo Finance • 20 days ago
CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025
About
CEO | Dr. Sean A. McCarthy DPHIL |
Address | 151 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 119 |
